# TriSalus Life Sciences, Inc.: Form 8-K, filed Apr 7, 2026

- Company: [TriSalus Life Sciences, Inc.](/companies/tlsi.md) (CIK 1826667)
- Form: 8-K
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 13:10 ET
- Period: 2026-04-01
- Accession: 0001628280-26-023991
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1826667/000162828026023991/tlsi-20260401.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1826667/000162828026023991/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1826667/000162828026023991/tlsi-20260401.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-023991. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.